Have your own idea? Try our Stock Screener
U.K. (FTSE) Pharma Industry Analysis
UpdatedAug 10, 2025
DataAggregated Company Financials
Companies15
- 7D-1.7%
- 3M2.0%
- 1Y-12.6%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 1.7%, driven by AstraZeneca declining 1.6%. On the other hand Allergy Therapeutics is actually up 9.4%. The industry has fallen 13% in the last year. Looking forward, earnings are forecast to grow by 13% annually.
Industry Valuation and Performance
Has the U.K. Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 10 Aug 2025 | UK£263.7b | UK£87.7b | UK£11.7b | 21.5x | 22.5x | 3x |
| Tue, 08 Jul 2025 | UK£254.9b | UK£86.1b | UK£10.6b | 25.4x | 24.1x | 3x |
| Thu, 05 Jun 2025 | UK£270.3b | UK£86.3b | UK£10.6b | 27x | 25.5x | 3.1x |
| Sat, 03 May 2025 | UK£268.3b | UK£87.2b | UK£10.1b | 26.7x | 26.5x | 3.1x |
| Mon, 31 Mar 2025 | UK£280.2b | UK£87.7b | UK£9.7b | 32.6x | 29x | 3.2x |
| Wed, 26 Feb 2025 | UK£289.6b | UK£88.6b | UK£9.4b | 31.5x | 30.7x | 3.3x |
| Fri, 24 Jan 2025 | UK£234.6b | UK£76.1b | UK£7.9b | 32.6x | 29.8x | 3.1x |
| Sun, 22 Dec 2024 | UK£220.2b | UK£75.3b | UK£7.8b | 30.8x | 28.3x | 2.9x |
| Tue, 19 Nov 2024 | UK£214.4b | UK£75.2b | UK£7.8b | 29.8x | 27.6x | 2.8x |
| Thu, 17 Oct 2024 | UK£255.4b | UK£72.5b | UK£9.1b | 31.1x | 28.2x | 3.5x |
| Sat, 14 Sep 2024 | UK£259.0b | UK£72.1b | UK£9.0b | 37.7x | 28.7x | 3.6x |
| Mon, 12 Aug 2024 | UK£268.9b | UK£73.2b | UK£9.1b | 39x | 29.5x | 3.7x |
| Wed, 10 Jul 2024 | UK£254.0b | UK£71.3b | UK£9.5b | 28.8x | 26.7x | 3.6x |
| Fri, 07 Jun 2024 | UK£269.9b | UK£71.3b | UK£9.5b | 31.4x | 28.3x | 3.8x |
| Sun, 05 May 2024 | UK£265.3b | UK£72.0b | UK£9.6b | 32.9x | 27.6x | 3.7x |
| Tue, 02 Apr 2024 | UK£245.1b | UK£70.9b | UK£9.7b | 31.8x | 25.2x | 3.5x |
| Thu, 29 Feb 2024 | UK£235.1b | UK£70.6b | UK£9.6b | 33.6x | 24.4x | 3.3x |
| Sat, 27 Jan 2024 | UK£237.3b | UK£68.9b | UK£10.7b | 35.9x | 22.2x | 3.4x |
| Mon, 25 Dec 2023 | UK£232.3b | UK£68.9b | UK£10.7b | 34.8x | 21.8x | 3.4x |
| Wed, 22 Nov 2023 | UK£227.0b | UK£69.4b | UK£10.7b | 54.6x | 21.1x | 3.3x |
| Fri, 20 Oct 2023 | UK£235.4b | UK£70.8b | UK£10.4b | 53.7x | 22.7x | 3.3x |
| Sun, 17 Sep 2023 | UK£245.3b | UK£70.0b | UK£10.3b | 53.5x | 23.8x | 3.5x |
| Tue, 15 Aug 2023 | UK£242.9b | UK£69.1b | UK£10.2b | 52.8x | 23.9x | 3.5x |
| Thu, 13 Jul 2023 | UK£226.1b | UK£67.0b | UK£7.8b | 55.5x | 29x | 3.4x |
| Sat, 10 Jun 2023 | UK£250.7b | UK£68.2b | UK£7.9b | 55.1x | 31.6x | 3.7x |
| Mon, 08 May 2023 | UK£258.0b | UK£68.0b | UK£7.9b | 57.3x | 32.6x | 3.8x |
| Wed, 05 Apr 2023 | UK£244.3b | UK£69.0b | UK£6.9b | 49.7x | 35.7x | 3.5x |
| Fri, 03 Mar 2023 | UK£239.2b | UK£70.8b | UK£7.0b | 51.8x | 34.3x | 3.4x |
| Sun, 29 Jan 2023 | UK£235.4b | UK£79.1b | UK£6.3b | 38.2x | 37.4x | 3x |
| Tue, 27 Dec 2022 | UK£245.2b | UK£80.1b | UK£6.3b | 37.7x | 38.7x | 3.1x |
| Thu, 24 Nov 2022 | UK£237.7b | UK£80.2b | UK£6.3b | 17.1x | 37.5x | 3x |
| Sat, 22 Oct 2022 | UK£217.0b | UK£81.0b | UK£3.7b | 20.9x | 59.4x | 2.7x |
| Mon, 19 Sep 2022 | UK£221.6b | UK£80.2b | UK£3.7b | 15.1x | 60.2x | 2.8x |
| Wed, 17 Aug 2022 | UK£240.6b | UK£77.8b | UK£3.8b | 15.1x | 64x | 3.1x |
Price to Earnings Ratio
64x
Current Industry PE
- Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.5x which is lower than its 3-year average PE of 32.6x.
- The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 46% per year over the last three years.
- Revenues for these companies have grown 4.0% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does U.K. Pharma compare with similar industries?
| GB Market | 3.24% | |
| Healthcare | -0.94% | |
| Pharma | -1.70% | |
| Pharma | -1.70% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AGY Allergy Therapeutics | UK£0.087 | 9.4% +UK£35.7m | 78.6% | PS7.5x | |
| ANCR Animalcare Group | UK£2.71 | 1.1% +UK£2.1m | -1.5% | PE38.8x | |
| INC Incanthera | UK£0.063 | 19.0% +UK£1.4m | -76.9% | PB4.5x | |
| STX Shield Therapeutics | UK£0.046 | 2.2% +UK£1.0m | 12.2% | PS2x | |
| NFX Nuformix | UK£0.00085 | 9.7% +UK£149.7k | -49.3% | PB2.1x |